Brief: Eloxx Pharma Gets FDA Clearance To Begin Single Ascending Dose Study Of ZKN-013

Eloxx Pharmaceuticals

02/05/2023 13:42

May 2 (Reuters) - Eloxx Pharmaceuticals Inc  ELOX.O :
    * ELOXX PHARMACEUTICALS ANNOUNCES FDA CLEARANCE TO BEGIN
SINGLE
ASCENDING DOSE STUDY OF ZKN-013

Source text for Eikon:  ID:nGNX8ghshC 
Further company coverage:  ELOX.O 

 ((Reuters.Briefs@thomsonreuters.com;))